Z-2-Nal-OH contains the amino acid side-chain motif of 2-naphthylalanine (2-Nal) in a free carboxylic acid form, where the N-terminus is protected as a Z (benzyloxycarbonyl, Cbz) carbamate. The molecule bears both an amino group (as the carbamate-protected nitrogen) and a carboxylic acid, while the 2-naphthyl side chain provides a hydrophobic aromatic functionality for incorporation into peptide frameworks. Z-2-Nal-OH is employed as a protected amino acid building block for stepwise peptide synthesis and for structure-activity or binding studies that require an aromatic, non-proteinogenic amino acid residue with a controlled N-protection state.
CAT No: CP27328
CAS No:65365-16-4
Synonyms/Alias:Z-2-Nal-OH;65365-16-4;AC1ODZXP;Z-L-2-Nal-OH;SCHEMBL4634963;MolPort-003-990-213;XBRPIBMAJOTVHG-IBGZPJMESA-N;ZINC2597008;7847AH;KM0922;AKOS025289401;AK170129;N-(benzyloxycarbonyl)-3-(2-naphthyl)-L-alanine;(2S)-3-naphthalen-2-yl-2-(phenylmethoxycarbonylamino)propanoicacid;(2S)-2-{[(benzyloxy)carbonyl]amino}-3-naphthalen-2-ylpropanoicacid;2-Naphthalenepropanoicacid,a-[[(phenylmethoxy)carbonyl]amino]-,(aS)-
2. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
5. High fat diet and GLP-1 drugs induce pancreatic injury in mice
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.